• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养保健品:开启监管框架的辩论。

Nutraceuticals: opening the debate for a regulatory framework.

机构信息

Department of Pharmacy, University of Napoli Federico II, Via D. Montesano, 49 -, 80131, Naples, Italy.

AIFA - Agenzia Italiana del Farmaco, Via del Tritone, 181 -, 00187, Rome, Italy.

出版信息

Br J Clin Pharmacol. 2018 Apr;84(4):659-672. doi: 10.1111/bcp.13496. Epub 2018 Feb 14.

DOI:10.1111/bcp.13496
PMID:29433155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5867125/
Abstract

Currently, nutraceuticals do not have a specific definition distinct from those of other food-derived categories, such as food supplements, herbal products, pre- and probiotics, functional foods, and fortified foods. Many studies have led to an understanding of the potential mechanisms of action of pharmaceutically active components contained in food that may improve health and reduce the risk of pathological conditions while enhancing overall well-being. Nevertheless, there is a lack of clear information and, often, the claimed health benefits may not be properly substantiated by safety and efficacy information or in vitro and in vivo data, which can induce false expectations and miss the target for a product to be effective, as claimed. An officially shared and accepted definition of nutraceuticals is still missing, as nutraceuticals are mostly referred to as pharma-foods, a powerful toolbox to be used beyond the diet but before the drugs to prevent and treat pathological conditions, such as in subjects who may not yet be eligible for conventional pharmaceutical therapy. Hence, it is of utmost importance to have a proper and unequivocal definition of nutraceuticals and shared regulations. It also seems wise to assess the safety, mechanism of action and efficacy of nutraceuticals with clinical data. A growing demand exists for nutraceuticals, which seem to reside in the grey area between pharmaceuticals and food. Nonetheless, given specific legislation from different countries, nutraceuticals are experiencing challenges with safety and health claim substantiation.

摘要

目前,营养保健品与其他源自食品的类别(如食品补充剂、草药产品、益生菌和益生元、功能性食品和强化食品)之间没有明确的定义区别。许多研究已经了解了食物中含有的具有药用活性成分的潜在作用机制,这些成分可能改善健康状况,降低患病风险,同时提高整体幸福感。然而,目前缺乏明确的信息,而且常常是声称的健康益处可能没有得到安全性和有效性信息或体外和体内数据的适当证实,这可能会产生虚假的期望,使产品无法达到预期的效果。由于营养保健品大多被称为药食同源,是一种在药物之前用于预防和治疗疾病的强大工具,如在可能尚未符合传统药物治疗标准的人群中,因此,营养保健品仍然缺乏官方认可的、公认的定义,以及相关的共享法规。因此,对营养保健品进行明确、统一的定义和相关规定显得尤为重要。用临床数据评估营养保健品的安全性、作用机制和疗效似乎也是明智的。人们对营养保健品的需求不断增长,它们似乎介于药品和食品之间的灰色地带。尽管如此,由于不同国家的具体法规,营养保健品在安全性和健康声称方面仍面临挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d1/5867125/c7237ebbbe75/BCP-84-659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d1/5867125/c098c614dd58/BCP-84-659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d1/5867125/c7237ebbbe75/BCP-84-659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d1/5867125/c098c614dd58/BCP-84-659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3d1/5867125/c7237ebbbe75/BCP-84-659-g002.jpg

相似文献

1
Nutraceuticals: opening the debate for a regulatory framework.营养保健品:开启监管框架的辩论。
Br J Clin Pharmacol. 2018 Apr;84(4):659-672. doi: 10.1111/bcp.13496. Epub 2018 Feb 14.
2
From pharmaceuticals to nutraceuticals: bridging disease prevention and management.从药品到营养保健品:架起疾病预防与管理的桥梁。
Expert Rev Clin Pharmacol. 2019 Jan;12(1):1-7. doi: 10.1080/17512433.2019.1552135. Epub 2018 Nov 30.
3
Nutraceuticals: Pharmacologically Active Potent Dietary Supplements.营养保健品:具有药理活性的强效膳食补充剂。
Biomed Res Int. 2022 Jul 4;2022:2051017. doi: 10.1155/2022/2051017. eCollection 2022.
4
Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.欧盟与营养保健品相关的法规,尤其侧重于植物源产品。
Toxicology. 2006 Apr 3;221(1):75-87. doi: 10.1016/j.tox.2006.01.014. Epub 2006 Feb 17.
5
Nutraceuticals and botanicals: overview and perspectives.营养保健品和植物药:概述与展望。
Int J Food Sci Nutr. 2012 Mar;63 Suppl 1:2-6. doi: 10.3109/09637486.2011.628012.
6
European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.欧洲关于营养保健品、膳食补充剂和功能性食品的法规:基于安全性的框架
Toxicology. 2006 Apr 3;221(1):59-74. doi: 10.1016/j.tox.2005.12.022. Epub 2006 Feb 15.
7
Science-based regulatory approach for safe nutraceuticals.基于科学的监管方法用于安全的营养保健品。
J Sci Food Agric. 2020 Nov;100(14):5079-5082. doi: 10.1002/jsfa.9381. Epub 2018 Nov 16.
8
The frontier between nutrition and pharma: The international regulatory framework of functional foods, food supplements and nutraceuticals.营养与制药的交界:功能性食品、食品补充剂和营养药物的国际监管框架。
Crit Rev Food Sci Nutr. 2020;60(10):1738-1746. doi: 10.1080/10408398.2019.1592107. Epub 2019 Mar 29.
9
The Basis of Structure/Function Claims of Nutraceuticals.营养保健品结构/功能宣称的依据。
Clin Rev Allergy Immunol. 2016 Dec;51(3):370-382. doi: 10.1007/s12016-016-8536-9.
10
Defining 'nutraceuticals': neither nutritious nor pharmaceutical.定义“营养保健品”:既非营养物也非药物。
Br J Clin Pharmacol. 2017 Jan;83(1):8-19. doi: 10.1111/bcp.12935. Epub 2016 Apr 25.

引用本文的文献

1
Obtaining and Characterization of Nutraceuticals Based on Linoleic Acid Derivatives Obtained by Green Synthesis and Their Valorization in the Food Industry.基于绿色合成获得的亚油酸衍生物的营养保健品的制备、表征及其在食品工业中的价值提升
Nutrients. 2025 Jul 24;17(15):2416. doi: 10.3390/nu17152416.
2
Nutraceutical Strategies for Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases.针对神经退行性疾病中线粒体功能障碍的营养保健品策略
Foods. 2025 Jun 23;14(13):2193. doi: 10.3390/foods14132193.
3
Management, Safety, and Efficacy Evaluation of Nutraceutical and Functional Food: A Global Perspective.

本文引用的文献

1
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.《药理学简明指南 2017/18:酶》
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S272-S359. doi: 10.1111/bph.13877.
2
Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system.含红曲米膳食补充剂的不良反应:来自意大利监测系统的病例评估
Br J Clin Pharmacol. 2017 Apr;83(4):894-908. doi: 10.1111/bcp.13171. Epub 2017 Jan 19.
3
Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.
营养保健品和功能性食品的管理、安全性及功效评估:全球视角
Compr Rev Food Sci Food Saf. 2025 Jul;24(4):e70222. doi: 10.1111/1541-4337.70222.
4
The Co-Evolution of Markets and Regulation in the Japanese Functional Food Industry: Balancing Risk and Benefit.日本功能性食品行业中市场与监管的共同演化:权衡风险与收益
Foods. 2025 Apr 30;14(9):1581. doi: 10.3390/foods14091581.
5
The need to update Ethiopia's national health and medicine policies: essential tools for informed decision-making in healthcare and the pharmaceutical sectors.更新埃塞俄比亚国家卫生与医学政策的必要性:医疗保健和制药部门明智决策的重要工具。
Front Public Health. 2025 Apr 25;13:1533710. doi: 10.3389/fpubh.2025.1533710. eCollection 2025.
6
Dietary Phytochemicals in Health and Disease: Mechanisms, Clinical Evidence, and Applications-A Comprehensive Review.饮食中的植物化学物质与健康和疾病:作用机制、临床证据及应用——全面综述
Food Sci Nutr. 2025 Mar 19;13(3):e70101. doi: 10.1002/fsn3.70101. eCollection 2025 Mar.
7
Penetration of Microplastics and Nanoparticles Through Skin: Effects of Size, Shape, and Surface Chemistry.微塑料和纳米颗粒经皮肤渗透:尺寸、形状及表面化学性质的影响
J Xenobiot. 2024 Dec 31;15(1):6. doi: 10.3390/jox15010006.
8
Nutraceuticals: a promising, yet unregulated Frontier in Healthcare.营养保健品:医疗保健领域一个前景广阔但尚未规范的前沿领域。
Eur J Clin Nutr. 2025 May;79(5):413-418. doi: 10.1038/s41430-024-01557-y. Epub 2024 Dec 16.
9
Driving Innovation Through Regulatory Design and Corporate Behaviour: A Case Study of Functional Food Industry in Japan.通过监管设计与企业行为推动创新:以日本功能性食品行业为例
Foods. 2024 Oct 18;13(20):3302. doi: 10.3390/foods13203302.
10
Nutraceuticals in osteoporosis prevention.用于预防骨质疏松症的营养保健品
Front Nutr. 2024 Oct 2;11:1445955. doi: 10.3389/fnut.2024.1445955. eCollection 2024.
搭建老龄化创新桥梁:欧洲创新伙伴关系(EIP)在积极健康老龄化方面各行动小组之间的协同作用
J Nutr Health Aging. 2017;21(1):92-104. doi: 10.1007/s12603-016-0803-1.
4
Nutraceuticals in hypercholesterolaemia: an overview.高胆固醇血症中的营养保健品:概述
Br J Pharmacol. 2017 Jun;174(11):1450-1463. doi: 10.1111/bph.13636. Epub 2016 Oct 29.
5
Different Toxicity Mechanisms for Citrinin and Ochratoxin A Revealed by Transcriptomic Analysis in Yeast.转录组分析揭示酵母中桔霉素和赭曲霉毒素A的不同毒性机制
Toxins (Basel). 2016 Sep 22;8(10):273. doi: 10.3390/toxins8100273.
6
Recent advances in complementary and replacement therapy with nutraceuticals in combating gastrointestinal illnesses.营养保健品在对抗胃肠道疾病中的补充和替代疗法的最新进展。
Clin Nutr. 2017 Aug;36(4):968-979. doi: 10.1016/j.clnu.2016.08.020. Epub 2016 Aug 30.
7
Nutraceuticals: A paradigm of proactive medicine.营养保健品:主动医学的范例。
Eur J Pharm Sci. 2017 Jan 1;96:53-61. doi: 10.1016/j.ejps.2016.09.003. Epub 2016 Sep 7.
8
Metabolic syndrome and subsequent risk of type 2 diabetes and cardiovascular disease in elderly women: Challenging the current definition.老年女性的代谢综合征及后续患2型糖尿病和心血管疾病的风险:对当前定义提出挑战
Medicine (Baltimore). 2016 Sep;95(36):e4806. doi: 10.1097/MD.0000000000004806.
9
Novel perspectives on therapeutic modulation of the gut microbiota.肠道微生物群治疗调节的新视角。
Therap Adv Gastroenterol. 2016 Jul;9(4):580-93. doi: 10.1177/1756283X16637819. Epub 2016 Apr 4.
10
Analysis of Citrinin in Cereals, Red Yeast Rice Dietary Supplement, and Animal Feed by Immunoaffinity Column Cleanup and LC with Fluorescence Detection.采用免疫亲和柱净化和带荧光检测的液相色谱法分析谷物、红曲米膳食补充剂及动物饲料中的桔霉素。
J AOAC Int. 2016 Jul;99(4):1025-1031. doi: 10.5740/jaoacint.16-0060. Epub 2016 Jun 22.